# Nautilus Biotechnology, Inc. to Report Q3 Results Before Market Open Oct. 27

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/41374
Published: 2026-10-26T21:52:28.000Z
Updated: 2026-10-26T21:52:28.000Z
Section: Business

> The consensus estimate calls for a loss of $0.14 per share and $210,000 in revenue.

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) is scheduled to announce third-quarter results before market open Tuesday, Oct. 27. The consensus estimate calls for a loss of $0.14 per share and revenue of $210,000.